Exiqon A/S Interim report for the first 3 months of 2008

Exiqon - Interim report for the first 3 months of 2008 (unaudited)

Summary: Exiqon's revenue increased by 76% to DKK 16.5 million. Product sales
increased 109% to DKK 14.2 million in the first three months of 2008, including
March sales through Oncotech Inc. Operating expenses amounted to DKK 43
million, and the loss for the period totaled DKK 25 million.

Exiqon A/S Interim report for the first 3 months of 2008 (unaudited)

Attachments